Literature DB >> 2874654

Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse.

J Miyagawa, T Hanafusa, A Miyazaki, K Yamada, H Fujino-Kurihara, H Nakajima, N Kono, K Nonaka, Y Tochino, S Tarui.   

Abstract

The submandibular glands of female non-obese diabetic (NOD) mice (22-26 weeks of age) were studied by light and electron microscopy. Mononuclear cells consisting mostly of lymphocytes were recognized in and among the acini and secretory ducts. Some parts of the secretory ducts and mucous acini surrounded by lymphocytes showed destructive changes. In the secretory ducts lymphocytes invaded the duct epithelial lining and the duct lumen was occluded by these cells. The duct epithelial cells in such lesions were extremely distorted and tonofilament bundles running in various directions were present in the cytoplasm. Lymphocytes were in close contact with the duct epithelial cells. In the mucous acini some acinar cells, which appeared to be compressed by the infiltrating lymphocytes, showed degenerative changes. Immunocytochemical study revealed that both T- and B-lymphocytes were involved, T-lymphocytes tending to occupy the center of the infiltrate, while B-lymphocytes occupied the periphery. Although autoantibody against duct epithelial cells was identified, damage to duct epithelial cells was not correlated with the presence of this antibody. The morphological changes in the submandibular gland of the NOD mouse are very similar to those reported in the salivary gland of patients with Sjögren's syndrome.

Entities:  

Mesh:

Year:  1986        PMID: 2874654     DOI: 10.1007/bf02899031

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  16 in total

Review 1.  Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes.

Authors:  L M Esteban; A G Baxter
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55.

Authors:  R E Hunger; S Müller; J A Laissue; M W Hess; C Carnaud; I Garcia; C Mueller
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Non-obese diabetic (NOD) mouse.

Authors:  G Papaccio
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice.

Authors:  Y Hayashi; M Utsuyama; C Kurashima; K Hirokawa
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 6.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

7.  Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren's syndrome.

Authors:  Weibao Xiao; Yalan Wu; Jingfa Zhang; Wen Ye; Guo-Tong Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-23       Impact factor: 3.117

8.  Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer.

Authors:  M J Clare-Salzler; J Brooks; A Chai; K Van Herle; C Anderson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.

Authors:  E-K Tensing; J Ma; M Hukkanen; H S Fox; T-F Li; J Törnwall; Y T Konttinen
Journal:  Rheumatol Int       Date:  2003-09-12       Impact factor: 2.631

10.  Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity.

Authors:  Anna Lonyai; Shohta Kodama; Douglas Burger; Denise L Faustman
Journal:  Immunol Cell Biol       Date:  2008-02-26       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.